DEVELOPING | Opioid manufacturer agrees to $150M settlement after class-action lawsuit led by B.C. asks for $60B
British Columbia says a proposed $150-million settlement with Purdue Pharma Canada has been reached for the recovery of health-care costs related to the sale and marketing of opioid-based pain medicines.
